FDA advisers vote in favor of authorizing Novavax COVID-19 vaccine
Officials hope that Novavax will be more accepted by people who have so far been hesitant to get vaccinated.
Stay updated with breaking news from Eric Rubin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Officials hope that Novavax will be more accepted by people who have so far been hesitant to get vaccinated.
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.
A panel of experts convened by the US drug regulator on Tuesday recommended the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy.
Advisers to the Food and Drug Administration overwhelmingly voted to recommend that it authorize Novavax's two-dose vaccine against COVID-19.